Geode Capital Management
VCNX

Geode Capital Management’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

Geode Capital Management’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,150
Closed -$10.7K – 4649
2023
Q4 		$10.7K Hold
1,150
– – ﹤0.01% 4581
2023
Q3 		$18.2K Sell
1,150
-41
-3% -$2.08K ﹤0.01% 4638
2023
Q2 		$89.1K Hold
1,191
– – ﹤0.01% 4371
2023
Q1 		$99.9K Hold
1,191
– – ﹤0.01% 4334
2022
Q4 		$164K Sell
1,191
-4
-0.3% -$496 ﹤0.01% 4202
2022
Q3 		$124K Buy
1,195
+9
+0.8% +$1.77K ﹤0.01% 4467
2022
Q2 		$268K Buy
1,186
+59
+5% +$15.1K ﹤0.01% 4092
2022
Q1 		$312K Buy
1,127
+516
+84% +$143K ﹤0.01% 4165
2021
Q4 		$134K Hold
611
– – ﹤0.01% 4629
2021
Q3 		$277K Buy
611
+115
+23% +$57.4K ﹤0.01% 4305
2021
Q2 		$291K Buy
496
+185
+59% +$97.8K ﹤0.01% 4179
2021
Q1 		$194K Buy
+311
New +$200K ﹤0.01% 4118

Other funds holding VCNX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
TC
Tacita Capital Toronto, Ontario, Canada $184M AUM 26.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management's VCNX Position: Q1 2024 in Review

Geode Capital Management sold out of Vaccinex, Inc. Common Stock (VCNX) in Q1 2024, closing a stake of 1,150 shares — an estimated $10.7K sold.

Geode Capital Management first reported a position in VCNX in Q1 2021 and held it in 12 quarters. The position peaked at $312K in Q1 2022. 12 funds tracked by Wall St. Rank hold VCNX as of Q1 2024.

  • Geode Capital Management reported no remaining Vaccinex, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Geode Capital Management sold 1,150 Vaccinex, Inc. Common Stock shares in Q1 2024, an estimated $10.7K.
  • Geode Capital Management first reported a position in Vaccinex, Inc. Common Stock in Q1 2021 and held it in 12 quarters.
  • Geode Capital Management's Vaccinex, Inc. Common Stock position peaked at $312K in Q1 2022.
  • 12 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2024.

Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.